The 8th Annual Collaborating for a Cure Ladies Luncheon benefitting the Samuel Waxman Cancer Research Foundation, took place at the T-Bar Restaurant in Southampton this past weekend.
The event was a tremendous success raising $100,000 towards cancer research. The luncheon honored Jean Shafiroff for her continual support of SWCRF and featured a live fashion show by renowned designer Kobi Halperin, who showcased his Fall 2021 fashions and introduced his newest blouse collection.
“For the past seven years the Ladies Luncheon was held in May at a private residence but had to be cancelled last year due to the Covid-19 pandemic,” said Marion Waxman, chair of the event. “Now with most people vaccinated, we were thrilled to bring donors and supporters together again, to raise vital funds for cancer research.”
Notable attendees included: Marion Waxman, Dr. Samuel Waxman, Pamela Morgan, Nancy Litman, Helen Vaysman, Maria Fishel, Chris Arlotta, Erica Fineberg, Andrea Wernick, NYS Assemblywoman Rebecca Seawright, Leesa Rowland, Karen Klopp, Randi Schatz, Maribel Lieberman, Nicole Noonan, Ruth Miller, Lucia Hwong Gordon, David Hochberg, Paulo Yoshida.
The foundation announced its commitment to funding renowned scientists around the world working on discovering new treatments for breast and ovarian cancers. Currently, SWCRF is investing in 13 researchers as part of its Women’s Cancer Research Program. With funds raised from this event, SWCRF will be expanding this program in 2022.
The event Chairs are Marion Waxman and Pamela Morgan with co-chairs Erica Linden-Fineberg, Nancy Litman, Lauren Silvers, and Helen Vaysman. The Committee includes Chris Arlotta, Karen Amster-Young, Maria Elena Christiansen, Maria Fishel, Katarina Frangenberg, Michelle Russell Johnson, Norah Lawlor, Deanna Passarelli, Andrea Wernick, and Marcy Whitman.
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe.
For more information about the SWCRF research, visit www.waxmancancer.org.